Wet AMD 3 Symposium

Related

• 

  Efficacy, Durability, and Safety of Faricimab in DME: 2-Year Results From the Phase 3 YOSEMITE and RHINE Trials

  Jennifer I. Lim, MD, FARVO, FASRS

  Updates from the Field

  2022

• 

  Fluctuations in Central Foveal Thickness and Vision Outcomes With AntiVEGF Therapy for Neovascular Age-Related Macular Degeneration

  Veeral S. Sheth, MD, MBA, FASRS, FACS

  Updates from the Field

  2020

• 

  Episode 2: Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration with Dr. Brian Ballio

  Keyvan Koushan, MD, FRCSC

  Member Podcasts

  2017